An in vitro study on the combination effect of metformin and N-Acetyl cysteine against hyperglycaemia-induced cardiac damage

dc.contributor.authorJohnson, Rabia
dc.contributor.authorSangweni, Nonhlakanipho F.
dc.contributor.authorMabhida, Sihle E.
dc.contributor.authorDludla, Phiwayinkosi V.
dc.contributor.authorMabasa, Lawrence
dc.contributor.authorRiedel, Sylvia
dc.contributor.authorChapman, Charna
dc.contributor.authorMosa, Rebamang Anthony
dc.contributor.authorKappo, Abidemi P.
dc.contributor.authorLouw, Johan
dc.contributor.authorMuller, Christo J. F.
dc.date.accessioned2020-03-06T13:00:57Z
dc.date.available2020-03-06T13:00:57Z
dc.date.issued2019-11-21
dc.description.abstractChronic hyperglycaemia is a major risk factor for diabetes-induced cardiovascular dysfunction. In a hyperglycaemic state, excess production of reactive oxygen species (ROS), coupled with decreased levels of glutathione, contribute to increased lipid peroxidation and subsequent myocardial apoptosis. N-acetylcysteine (NAC) is a thiol-containing antioxidant known to protect against hyperglycaemic-induced oxidative stress by promoting the production of glutathione. While the role of NAC against oxidative stress-related cardiac dysfunction has been documented, to date data is lacking on its beneficial e ect when used with glucose lowering therapies, such as metformin (MET). Thus, the aim of the study was to better understand the cardioprotective e ect of NAC plus MET against hyperglycaemia-induced cardiac damage in an H9c2 cardiomyoblast model. H9c2 cardiomyoblasts were exposed to chronic high glucose concentrations for 24 h. Thereafter, cells were treated with MET, NAC or a combination of MET and NAC for an additional 24 h. The combination treatment mitigated high glucose-induced oxidative stress by improving metabolic activity i.e. ATP activity, glucose uptake (GU) and reducing lipid accumulation. The combination treatment was as e ective as MET in diminishing oxidative stress, lipid peroxidation and apoptosis. We observed that the combination treatment prevented hyperglycaemic-induced cardiac damage by increasing GLUT4 expression and mitigating lipid accumulation via phosphorylation of both AMPK and AKT, while decreasing nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), as well as protein kinase C (PKC), a known activator of insulin receptor substrate-1 (IRS-1), via phosphorylation at Ser307. On this basis, the current results support the notion that the combination of NAC and MET can shield the diabetic heart against impaired glucose utilization and therefore its long-term protective e ect warrants further investigation.en_ZA
dc.description.departmentBiochemistryen_ZA
dc.description.departmentGeneticsen_ZA
dc.description.departmentMicrobiology and Plant Pathologyen_ZA
dc.description.librarianam2020en_ZA
dc.description.sponsorshipThe Biomedical Research and innovation Platform (BRIP) of the South African Medical Research Council (SAMRC) as well as the National Research Foundation (NRF) Thuthuka Programme (Grant 10726).en_ZA
dc.description.urihttp://www.mdpi.com/journal/nutrientsen_ZA
dc.identifier.citationJohnson, R., Sangweni, N.F., Mabhida, S.E. et al. 2019, 'An in vitro study on the combination effect of metformin and N-Acetyl cysteine against hyperglycaemia-induced cardiac damage', Nutrients, vol. 11, art. 2850, pp. 1-19.en_ZA
dc.identifier.issn2072-6643
dc.identifier.other10.3390/nu11122850
dc.identifier.urihttp://hdl.handle.net/2263/73663
dc.language.isoenen_ZA
dc.publisherMDPI Publishingen_ZA
dc.rights© 2019 by the authors. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.en_ZA
dc.subjectOxidative stressen_ZA
dc.subjectDiabetesen_ZA
dc.subjectApoptosisen_ZA
dc.subjectMetforminen_ZA
dc.subjectCardiovascularen_ZA
dc.subjectChronic hyperglycaemiaen_ZA
dc.subjectDiabetes-induced cardiovascular dysfunctionen_ZA
dc.subjectReactive oxygen species (ROS)en_ZA
dc.subjectN-acetylcysteine (NAC)en_ZA
dc.subjectMetformin (MET)en_ZA
dc.titleAn in vitro study on the combination effect of metformin and N-Acetyl cysteine against hyperglycaemia-induced cardiac damageen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Johnson_In_2019.pdf
Size:
3.61 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: